Low muscle mass, malnutrition, sarcopenia, and associations with survival in adults with cancer in the UK Biobank cohort
Journal of Cachexia, Sarcopenia and Muscle · 2023-08 · 14 (4) · 1775-1788
DOI: 10.1002/jcsm.13256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 22.05.2023. Verfasst von Nicole Kiss und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Physical Activity and Nutrition, Deakin University, Geelong, Australia. Hauptthemen laut MEDLINE: Malnutrition, Neoplasms, Sarcopenia. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mangelernährung
Abstract (Originalsprache)
Background
Low muscle mass (MM) is a common component of cancer‐related malnutrition and sarcopenia, conditions that are all independently associated with an increased risk of mortality. This study aimed to (1) compare the prevalence of low MM, malnutrition, and sarcopenia and their association with survival in adults with cancer from the UK Biobank and (2) explore the influence of different allometric scaling (height [m 2 ] or body mass index [BMI]) on low MM estimates.
Methods
Participants in the UK Biobank with a cancer diagnosis within 2 years of the baseline assessment were identified. Low MM was estimated by appendicular lean soft tissue (ALST) from bioelectrical impedance analysis derived fat‐free mass. Malnutrition was determined using the Global Leadership in Malnutrition criteria. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People criteria (version 2). All‐cause mortality was determined from linked national mortality records. Cox‐proportional hazards models were fitted to estimate the effect of low MM, malnutrition, and sarcopenia on all‐cause mortality.
Results
In total, 4122 adults with cancer (59.8 ± 7.1 years; 49.2% male) were included. Prevalence of low MM (8.0% vs. 1.7%), malnutrition (11.2% vs. 6.2%), and sarcopenia (1.4% vs. 0.2%) was higher when MM was adjusted using ALST/BMI compared with ALST/height 2 , respectively. Low MM using ALST/BMI identified more cases in participants with obesity (low MM 56.3% vs. 0%; malnutrition 50% vs. 18.5%; sarcopenia 50% vs. 0%). During a median 11.2 (interquartile range: 10.2, 12.0) years of follow up, 901 (21.7%) of the 4122 participants died, and of these, 744 (82.6%) deaths were cancer‐specific All conditions were associated with a higher hazard of mortality using either method of MM adjustment: low MM (ALST/height 2 : HR 1.9 [95% CI 1.3, 2.8], P = 0.001; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; malnutrition (ALST/height 2 : HR 2.5 [95% CI 1.1, 1.7], P = 0.005; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; sarcopenia (ALST/height 2 : HR 2.9 [95% CI 1.3, 6.5], P = 0.013; ALST/BMI: HR 1.6 [95% CI 1.0, 2.4], P = 0.037).
Conclusions
In adults with cancer, malnutrition was more common than low MM or sarcopenia, although all conditions were associated with a higher mortality risk, regardless of the method of adjusting for MM. In contrast, adjustment of low MM for BMI identified more cases of low MM, malnutrition, and sarcopenia overall and in participants with obesity compared with height adjustment, suggesting it is the preferred adjustment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Physical Activity and Nutrition, Deakin University, Geelong, Australia.
- Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Department of Agricultural, Food and Nutrition Science, University of Alberta, Edmonton, Canada.
- Melbourne School of Health Sciences, University of Melbourne, Parkville, Australia.
- Department of Physiotherapy, University of Melbourne, Parkville, Australia.
- Institute for Intelligent Systems Research and Innovation, Deakin University, Geelong, Australia.
ORCID-Profile: Nicole Kiss
Zitieren
APA
Kiss, N., Prado, C. M., Daly, R. M., Denehy, L., Edbrooke, L., Baguley, B. J., Fraser, S. F., Khosravi, A., & Abbott, G. (2023). Low muscle mass, malnutrition, sarcopenia, and associations with survival in adults with cancer in the UK Biobank cohort. Journal of Cachexia, Sarcopenia and Muscle, 14(4), 1775-1788. https://doi.org/10.1002/jcsm.13256
Vancouver
Kiss N, Prado CM, Daly RM, Denehy L, Edbrooke L, Baguley BJ, et al. Low muscle mass, malnutrition, sarcopenia, and associations with survival in adults with cancer in the UK Biobank cohort. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(4):1775-1788. doi:10.1002/jcsm.13256
BibTeX
@article{Kiss2023,
author = {Kiss, Nicole and Prado, Carla M and Daly, Robin M and Denehy, Linda and Edbrooke, Lara and Baguley, Brenton J and Fraser, Steve F and Khosravi, Abbas and Abbott, Gavin},
title = {Low muscle mass, malnutrition, sarcopenia, and associations with survival in adults with cancer in the UK Biobank cohort},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2023},
volume = {14},
number = {4},
pages = {1775--1788},
doi = {10.1002/jcsm.13256}
}
EUVIMED